Cardiac Surgery Instruments Market

Cardiac Surgery Instruments Market Analysis

The Cardiac Surgery Instruments Market size is estimated at USD 2.06 billion in 2025, and is expected to reach USD 2.91 billion by 2030, at a CAGR of 7.18% during the forecast period (2025-2030).

Cardiac surgery instruments are devices used during cardiac surgeries, and factors such as the rising burden of cardiac diseases coupled with the growing number of surgical procedures are projected to boost the market's growth over the study period. Moreover, a notable rise in the elderly population is expected to fuel the need for cardiac surgeries as they are more susceptible to cardiac diseases.

The notable burden of cardiac diseases will likely accelerate the demand for cardiac procedures, thereby supporting the market's growth over the coming years. For instance, according to April 2023 data from the Canadian Cardiovascular Society, atrial fibrillation (AFib) is one of the recurrent types of arrhythmia in clinical practice. It affects around 1% to 2% of the general population, and its risk increases with increasing age. This substantial burden of AFib will likely propel the demand for AFib surgeries like atrial fibrillation ablation, among others, thereby supporting the market growth.

Moreover, according to the data released by the British Heart Foundation in January 2024, around 7.6 million people were living with a heart or circulatory disease in the United Kingdom in 2023. As per the same source, around 80% of people with heart and circulatory diseases had at least one other health condition. This substantial burden of cardiac diseases are likely to expand surgical landscape for these conditions, thereby accelerating the utilization of cardiac devices like forceps, clams among others during surgeries.

Also, the increase in cardiac surgical procedures is another factor projected to foster the demand for surgical instruments, thereby supporting market growth. For instance, according to 2024 updated data from the Nationwide Children’s Hospital, United States, around 1 million different cardiac surgical procedures are performed in the United States every year. In addition, at Nationwide Children’s Hospital, the number of ASD (Atrial Septal Defect) closure procedures significantly increased from 13 in 2022 to 22 in 2023. This substantial landscape of cardiac procedures is likely to bolster the demand for cardiac surgery instruments, thereby fostering market growth.

Also, several research studies highlighted significant volumes of cardiac procedures. For instance, the study published in PubMed Central in April 2024 concluded that there was a significant rise in the number of cardiac surgeries performed over the past years, reflecting an increasing demand for healthcare services. This trend highlighted the necessity for healthcare providers to adapt their strategies to meet the growing needs of the patient population. Such a notable volume of cardiac surgical procedures is poised to offer significant growth opportunities for the market.

Furthermore, the growing demand for advanced cardiac surgical instruments and rising introductions of innovative cardiac surgical instruments are projected to strengthen the industry's growth over the coming years. For instance, in August 2024, DePuy Synthes, the Orthopaedics Company of Johnson & Johnson and part of Johnson & Johnson MedTech launched the MatrixSTERNUM Fixation System, a plate and screw fixation solution designed to stabilize the chest wall following open-heart and chest surgeries.

This advanced system aimed to meet patient needs in the operating room by offering enhanced locking strength, expedited chest fixation, and thinner, low-profile plates compared to competitive products. Such introductions of advanced surgical instruments are anticipated to propel the industry’s growth over the coming years.

Consequently, the above-mentioned factors, such as the rising prevalence of cardiac diseases, the growing number of surgical procedures, and the introduction of advanced cardiac surgical instruments, are projected to boost the market growth over the study period. Whereas the adoption of alternative surgical methods are likely to hinder market growth over the coming years.

Cardiac Surgery Instruments Market Trends

Hospitals and Clinics Segment is Expected to Hold Largest Market Share of the Cardiac Surgery Instruments Market

Hospitals and cardiac centers are expected to hold the largest share in the end-user segment, and its growth is likely to be driven by factors such as rising demand for cardiac surgical instruments across hospitals, rising number of cardiac procedures in hospitals, and several public-private efforts to strengthen cardiac procedures in hospitals and cardiac centers are further projected to boost the segment growth over the study period.

Various programs and initiatives launched by hospitals/cardiac centers to support heart surgeries are anticipated to propel the segment expansion over the coming years. For instance, in April 2023, MD Heart Center announced the launch of its new open-heart surgery program in collaboration with New York-Presbyterian/Columbia University Irving Medical Center. This program, the first of its kind in Orange County, enabled the local performance of complex cardiac procedures, allowing patients to receive expert heart surgery care without the burden of traveling far from their families.

Similarly, in December 2024, Anbu Hospital opened its cutting-edge Cardiac Surgery Department, which provided advanced procedures, including bypass grafting and valve replacement surgeries. This establishment significantly minimized travel requirements and enhanced heart attack survival rates while also prioritizing preventive care to improve community heart health. Such programs undertaken by hospitals/cardiac centers to improve the landscape of cardiac procedures are projected to bolster segment growth over the coming years.

Moreover, several efforts taken by hospitals to improve the accessibility and affordability of cardiac surgical procedures are further expected to offer growth opportunities for the segment. For instance, in January 2023, Aster Medcity launched a special cardiac surgery package for underprivileged individuals following the successful completion of 250 minimally invasive cardiac surgeries. The hospital is known for its excellent cardiology services and advanced surgical capabilities in Kochi, Kerala. Such key efforts by hospitals to improve the affordability of cardiac procedures are expected to boost segment expansion over the coming years.

Hence, the above-mentioned factors comprising the rising number of cardiac centers and hospitals offering cardiac surgeries coupled with several efforts by hospitals to improve the cardiac surgery landscape are projected to augment the adoption rates of cardiac surgical instruments, thereby supporting the market growth.

North America is Expected to Hold Significant Market Share In the Cardiac Surgery Instruments Market Over the Forecast Period

North America is expected to be the largest market in the cardiac surgery instruments market. The country’s growth is majorly driven by factors such as the growing burden of cardiac diseases in the United States coupled with a notable rise in the elderly population. In addition, several government initiatives to fuel awareness of cardiac procedures in the country are further poised to drive the regional market growth over the coming years.

The notable burden of cardiac diseases in the country is likely to fuel the need for surgical procedures to manage complications associated with these conditions, thereby fueling the demand for cardiac surgical instruments. For instance, according to the data updated by the Centers for Disease Control and Prevention in May 2023, every 40 seconds, a heart attack occurs in the United States. Also, about 805,000 Americans experience a heart attack each year. Hence, the rising burden of cardiovascular diseases in the coming years will increase the demand for surgical procedures to reduce the risk of heart attack and failure, thereby fueling the usage of surgical instruments.

Additionally, the rising geriatric population is also expected to drive market growth in the United States. For instance, the data published by the Population Reference Beaureu in January 2024 indicated that the number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050 (a 47% increase).

The 65-and-older age group's share of the total population is projected to rise from 17% to 23% in the United States. This rise in the geriatric population, which is prone to developing cardiovascular diseases, is expected to drive the demand for surgical procedures, thereby creating growth opportunities for the market.

Furthermore, the establishment of new cardiac care facilities in North America and the increased number of cardiac procedures performed in such facilities are further expected to fuel the adoption of cardiac surgery instruments, thereby fueling the regional market. For instance, in October 2023, the University Health Network (UHN) hospital of Canada started offering a new treatment option for pulmonary heart valve replacement in Canada. Hence, such initiatives are ultimately expected to spur the adoption of surgery instruments during surgery procedures, thereby expanding the market growth.

Therefore, the above-mentioned factors, including the rising burden of cardiac diseases in North America coupled with the growing elderly population in the region are projected to boost the regional market growth over the coming years.

Cardiac Surgery Instruments Industry Overview

The cardiac surgery instruments market is characterized by intense competition and a semi-consolidated structure, featuring numerous prominent companies that hold significant market share. This landscape includes several established international firms known for their significant presence. Key players in the cardiac surgery instruments market are actively pursuing various organic and inorganic strategies to enhance their business opportunities. Notable companies operating in this market include, BD, B. Braun SE, Teleflex Incorporated, Medline Industries, Inc., KLS Martin Group., Murray Surgical, Sklar, Wexler Surgical among others.

Cardiac Surgery Instruments Market Leaders

Cardiac Surgery Instruments Market News

• November 2023: Surtex Instruments unveiled its innovative "Infinex" series of microsurgery instruments at MEDICA 2023, emphasizing enhanced control, precision, and surgical outcomes. Engineered in Germany, the series features unique diamond-dusted jaws and precision-crafted tools, marking a significant advancement in microsurgery technology that prioritizes patient recovery and surgical excellence.
• February 2023: Cardiac Services recently announced a partnership with Wexler Surgical to enhance their surgical instrument offerings. This collaboration seeks to provide a range of high-quality instruments for various surgical specialties including cardiovascular, supported by a 15-year warranty and stringent quality inspections. The products were introduced at a significant medical meeting, showcasing the commitment to innovation and surgeon satisfaction.